Matthew Strobeck, Director at BIODESIX INC (BDSX), bought 204,173 shares at $18.00 ($2.9M) on 2020-10-30, disclosed to the SEC on 2020-11-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,973 | $0 | 0.0% |
| 2 | $14.40 | 3,522 | $51K | 1.7% |
| 3 | $14.40 | 18,714 | $269K | 9.2% |
| 4 | $14.40 | 76,631 | $1.1M | 37.7% |
| 5 | $18.00 | 83,333 | $1.5M | 51.3% |
| Total | $14.32 avg | 204,173 |
| $2.9M |
| 100% |
| Filing → |
| AZYO | BUY | 2023-02-13 | $398K | — | Filing → |
| BDSX | BUY | 2022-11-21 | $5.4M | — | Filing → |
| BDSX | BUY | 2022-04-11 | $2.0M | — | Filing → |